RECURRENT BREAST CARCINOMA
Clinical trials for RECURRENT BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers: drug targets DNA repair weakness
Disease control Recruiting nowThis phase 2 trial is testing the drug talazoparib in people with advanced solid tumors that have specific mutations in DNA repair genes. Talazoparib works by blocking a protein called PARP, which cancer cells use to fix their damaged DNA, leading to cancer cell death. The study …
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Measles virus turned against breast cancer tumors
Disease control Recruiting nowThis early-phase trial is testing a modified measles virus (MV-s-NAP) that is injected directly into tumors in people with metastatic breast cancer. The virus is designed to kill cancer cells and also carry an extra protein to boost the immune response. Researchers are monitoring…
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Radioactive 'Smart Bomb' targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis phase II trial is testing a radioactive drug called 177Lu-DOTATATE in 10 people with stage IV or recurrent breast cancer. The drug seeks out cancer cells that have a specific receptor (SSTR2) and delivers radiation to kill them. The goal is to see if it can shrink tumors and…
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Second chance at breast preservation: new study tests repeat radiation
Disease control Recruiting nowThis study explores whether women with recurrent breast cancer can safely have breast-conserving surgery and a second round of radiation instead of full mastectomy. It will enroll 60 patients who had prior radiation at least 3 years ago and have small, localized tumors. The goal …
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: NA • Sponsor: Turku University Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Custom-Made vaccine takes on aggressive breast cancer
Disease control Recruiting nowThis early-phase trial is testing a personalized vaccine made from a patient's own tumor, given alone or with immune-boosting drugs (pembrolizumab or ipilimumab), for triple negative breast cancer. The goal is to see if the vaccine is safe and can train the immune system to attac…
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
One-Shot radiation before second breast surgery: a new hope for recurrence?
Disease control Recruiting nowThis study tests whether a single, high dose of radiation given before repeat breast-conserving surgery is safe and effective for women whose breast cancer has returned after previous treatment. The trial will enroll 25 women aged 50 or older with small, low-risk tumors. The goal…
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
2000 patients to fuel breast cancer discoveries
Knowledge-focused Recruiting nowThis study collects tumor samples and medical information from 2000 people with breast cancer that has spread or come back. The goal is to create a resource for researchers to learn more about how the disease progresses and responds to treatments. No new treatments are tested her…
Matched conditions: RECURRENT BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Can heart drugs shield cancer patients from chemo damage?
Knowledge-focused Recruiting nowThis study looks at heart problems in people with HER2+ breast cancer that has spread. All participants are taking trastuzumab-based treatment. The main goal is to see how often heart issues occur, especially in those also taking beta blockers or similar heart medications. A smal…
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC